Guardant’s test analyzes circulating tumor DNA that is then used to identify patients with BRAF V600E-mutant metastatic colorectal cancer who may benefit from treatment with the Braftovi combo therapy ...

A Pfizer drug recently awarded accelerated FDA approval in colorectal cancer now has additional data showing it met key goals in its pivotal study, results that could support an application seeking ...

Add Yahoo as a preferred source to see more of our stories on Google. Metformin is listed as one of the World Health Organization's "essential" medicines. The cheap, generic drug is seen as a global ...

Colon cancer patients could live longer if they take GLP-1 drugs like Ozempic and Wegovy, a new study suggests. Researchers at UC San Diego studied more than 6,800 patients who were taking one of ...

Immunotherapy uses the power of your immune system to fight your cancer. One type of immunotherapy is called an immune checkpoint inhibitor. Your immune system has built-in checkpoints that help it ...

Oxaliplatin, a drug to fight colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends, according to a Johns Hopkins news release. Johns ...

Researchers in Sweden have identified an unexpected biological mechanism that could influence future cancer treatments. Scientists in Sweden have uncovered an unexpected anti-cancer effect from a ...

Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...

Also from GiCS: adjuvant immunotherapy in liver cancer, novel combo for pancreas cancer ...

Metformin is the most widely prescribed diabetes drug in the world. Scientists believe the drug has some colon-cancer prevention benefits. New research provides hints about its use as a supplemental ...